Stephen Mandel Dexcom Inc Transaction History

Lone Pine Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $187 Million - $235 Million	-1,441,227 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $45.6 Million - $61.1 Million	-427,060 Reduced 22.86%	1,441,227 $788 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $40.9 Million - $54.5 Million	-504,861 Reduced 21.27%	1,868,287 $798 Million
Q1 2021 May 18, 2021	BUY	$84.79 - $104.74 $8.93 Million - $11 Million	105,339 Added 4.64%	2,373,148 $853 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $141 Million - $189 Million	1,804,722 Added 389.72%	2,267,809 $838 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $11.8 Million - $14 Million	123,541 Added 36.38%	463,087 $191 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $21.3 Million - $35.8 Million	339,546 New	339,546 $138 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $50.6 Million - $80.1 Million	-1,058,895 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $38.8 Million - $60.7 Million	1,058,895 New	1,058,895 $232 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Lone Pine Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Lone Pine Capital LLC and Stephen Mandel with notifications on news.